New hope for Hard-to-Treat lung cancer: experimental drug combo enters trial
Disease control
Recruiting now
This study tests an experimental drug called JBI-802, either alone or with the immunotherapy pembrolizumab, in 30 adults with advanced lung cancer that has a specific genetic change (STK11 mutation). The main goals are to check safety and see if the treatment can shrink tumors or…
Phase: PHASE2 • Sponsor: The Christ Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC